Interpace Biosciences Inc Revenue Y/Y
What is the Revenue Y/Y of Interpace Biosciences Inc?
The Revenue Y/Y of Interpace Biosciences Inc is -1.31%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with revenue y/y similar to Interpace Biosciences Inc
- Textron has Revenue Y/Y of -1.35%
- Universal Store Hldg Ltd has Revenue Y/Y of -1.35%
- Ruicheng (China) Media has Revenue Y/Y of -1.33%
- BlackRock Muni New York Intermediate Duration Fund has Revenue Y/Y of -1.33%
- Qorvo has Revenue Y/Y of -1.32%
- GreenSky Inc has Revenue Y/Y of -1.31%
- Interpace Biosciences Inc has Revenue Y/Y of -1.31%
- MSB has Revenue Y/Y of -1.31%
- Atlas Engineered Products has Revenue Y/Y of -1.31%
- Mulsanne has Revenue Y/Y of -1.31%
- IRESS has Revenue Y/Y of -1.31%
- Taro Pharmaceutical Industries has Revenue Y/Y of -1.31%
- Motorsport Gaming US has Revenue Y/Y of -1.30%